Sheaff Brock Investment Advisors »

Crispr Therapeutics shares owned by Sheaff Brock Investment Advisors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Sheaff Brock Investment Advisors from 13F filings

Historical chart of Sheaff Brock Investment Advisors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Sheaff Brock Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Sheaff Brock Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $208k 3.3k 62.60

More positions owned by Sheaff Brock Investment Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple Call Call Option (Principal) (AAPL)
Nvidia Corporation Call Call Option (Principal) (NVDA)
Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
Amazon (AMZN)
Listed Fd Tr Dividend Perfmrs (IPDP)
Cisco Systems (CSCO)
Home Depot (HD)
JPMorgan Chase & Co. (JPM)
Invesco Qqq Tr Put Put Option (Principal) (QQQ)
Oracle Corporation (ORCL)
Cme (CME)
Kla Corp Com New (KLAC)
Iron Mountain (IRM)

View all positions for Sheaff Brock Investment Advisors

Top funds holding Crispr Therapeutics

ARK Investment Management
Nikko Asset Management Americas
Sumitomo Mitsui Trust Holdings
Citadel Advisors
Vanguard Group
NEA Management Company
Caption Management
Bellevue Group
Credit Suisse
T. Rowe Price Associates
Bank of America Corporation
Dimensional Fund Advisors
Voloridge Investment Management
Ikarian Capital
Charles Schwab Investment Management

View all funds holding Crispr Therapeutics